GENFIT: Half-Year report of Liquidity Contract with Crédit Industriel et Commercial

July 9, 2019

Lille (France), Cambridge (Massachusetts, United States), July 9, 2019 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases, today announced the half-year report of its liquidity contract with Crédit Industriel et Commercial.

Under the liquidity contract granted to Crédit Industriel et Commercial, the following resources appeared on the liquidity account on June 30th 2019:

  • 54 112 shares
  • € 384 222,99

During the first half 2019, the following transactions were carried out:

  • Number of executions on buy side: 1 751
  • Number of executions on sell side: 2 430
  • Traded volume on buy side: 387 272 shares for € 7 771 810,66
  • Traded volume on sell side: 361 071 shares for € 7 386 184,22

As a reminder, the following resources appeared on the liquidity account as of December 31, 2018:

  • 27 911 shares
  • € 769 849,43

About GENFIT

GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved treatments. GENFIT is a leader in the field of nuclear receptor-based drug discovery with a rich history and strong scientific heritage spanning almost two decades. Its most advanced drug candidate, elafibranor, is currently being evaluated in a pivotal Phase 3 clinical trial (“RESOLVE-IT”) as a potential treatment for NASH, and GENFIT plans to initiate a Phase 3 clinical trial in PBC later this year following its positive Phase 2 results. As part of GENFIT’s comprehensive approach to clinical management of NASH patients, the company is also developing a new, non-invasive and easy-to-access blood-based in vitro diagnostic test to identify patients with NASH who may be appropriate candidates for drug therapy. With facilities in Lille and Paris, France, and Cambridge, MA, USA, the Company has approximately 160 employees. GENFIT is a public company listed on the Nasdaq Global Select Market and in compartment B of Euronext’s regulated market in Paris (Nasdaq and Euronext: GNFT). www.genfit.com

CONTACT

GENFIT | Investors

Naomi EICHENBAUM – Investor Relations | Tel: +1 (617) 714 5252 | investors@genfit.com

PRESS RELATIONS | Media

Hélène LAVIN – Press relations | Tel: +333 2016 4000 | helene.lavin@genfit.com

APPENDIX

H1 2019

 

Buy side

Sell side

Date

Number of transactions

Number of shares

Traded volume in EUR

Number of transactions

Number of shares

Traded volume in EUR

TOTAL

1 751

387 272

7 771 810,66

2 430

361 071

7 386 184,22

02/01/2019

7

1291

22 262,25

95

3958

68 594,80

03/01/2019

4

661

11 905,20

11

1861

33 883,00

04/01/2019

4

601

10 880,84

6

1201

21 797,84

07/01/2019

8

1501

27 240,40

13

1901

34 701,40

08/01/2019

10

2683

49 751,59

8

1186

22 051,28

09/01/2019

31

4520

83 726,09

27

3071

57 260,60

10/01/2019

7

558

10 134,16

4

856

15 656,49

11/01/2019

6

849

15 219,48

4

436

7 873,80

14/01/2019

7

2666

46 506,40

2

293

5 165,78

15/01/2019

5

581

10 404,77

23

3282

58 037,92

16/01/2019

9

1781

32 926,97

11

1781

32 968,57

17/01/2019

8

4765

85 349,07

10

776

13 978,77

18/01/2019

3

101

1 796,04

29

4090

73 367,26

21/01/2019

9

1293

23 249,84

9

1293

23 406,12

22/01/2019

9

1552

27 634,27

1

1

17,98

23/01/2019

5

1184

21 235,32

19

2342

42 023,08

24/01/2019

2

289

5 187,60

1

1

18,00

25/01/2019

2

291

5 301,77

5

585

10 582,29

28/01/2019

2

291

5 223,45

1

1

17,95

29/01/2019

6

850

15 182,85

7

850

15 282,10

30/01/2019

7

2501

44 828,07

10

1584

28 521,26

31/01/2019

11

1501

27 013,23

1

1

18,23

01/02/2019

4

1001

18 018,10

4

1501

27 268,10

04/02/2019

3

350

6 327,43

3

350

6 309,73

05/02/2019

2

296

5 360,31

16

2441

44 932,71

06/02/2019

5

301

5 681,97

8

581

11 002,77

07/02/2019

16

1904

35 153,79

13

1179

21 868,53

08/02/2019

32

3399

60 817,46

5

493

8 896,88

11/02/2019

3

414

7 408,78

1

1

18,04

12/02/2019

12

2024

36 241,58

17

2724

48 941,07

13/02/2019

31

7124

128 317,28

13

2286

41 259,51

14/02/2019

7

851

15 288,10

29

3775

68 134,96

15/02/2019

3

595

10 794,16

17

2428

44 135,49

18/02/2019

5

835

15 202,50

9

835

15 279,92

19/02/2019

14

2710

50 715,36

48

7775

152 405,79

20/02/2019

16

2866

59 532,52

20

2866

60 032,48

21/02/2019

13

1665

35 162,14

19

1665

35 189,74

22/02/2019

2

501

10 361,18

4

501

10 411,18

25/02/2019

4

337

6 942,20

3

337

6 947,00

26/02/2019

4

260

5 314,36

2

260

5 314,32

27/02/2019

3

511

10 567,18

1

1

20,62

28/02/2019

13

1445

31 132,92

50

7590

164 811,64

01/03/2019

4

625

13 809,70

13

1025

22 614,40

04/03/2019

7

681

16 057,04

21

2632

61 285,82

05/03/2019

12

1451

33 078,56

22

2183

51 041,48

06/03/2019

12

1269

29 117,80

7

261

6 149,40

07/03/2019

13

1185

26 691,68

9

1185

26 853,60

08/03/2019

12

1295

28 916,28

4

701

15 803,04

11/03/2019

9

1343

31 052,58

25

3401

79 450,76

12/03/2019

8

823

18 892,56

8

823

18 940,90

13/03/2019

2

231

5 317,40

4

461

10 639,60

14/03/2019

4

466

10 884,30

4

453

10 681,62

15/03/2019

12

1509

35 033,54

12

1353

31 384,00

18/03/2019

9

1313

29 823,72

13

1573

35 832,46

19/03/2019

1

1

22,94

1

1

22,94

20/03/2019

3

461

10 787,06

14

3272

76 653,60

21/03/2019

4

679

15 743,84

9

651

15 103,08

22/03/2019

10

3980

89 600,54

15

1423

32 856,78

25/03/2019

17

4825

103 727,18

2

239

5 239,00

26/03/2019

17

2035

43 909,86

64

10672

232 497,68

27/03/2019

25

8460

166 901,32

4

323

6 515,58

28/03/2019

24

3603

74 838,08

14

2003

41 666,12

29/03/2019

19

2065

44 152,86

11

1165

24 962,58

01/04/2019

7

3186

68 695,36

27

5186

112 629,46

02/04/2019

9

1146

24 529,20

8

1146

24 634,20

03/04/2019

13

2891

62 300,18

10

891

19 350,50

04/04/2019

11

2651

56 227,50

11

1151

24 389,30

05/04/2019

3

348

7 365,66

9

1698

36 370,06

08/04/2019

4

493

11 056,84

49

11542

262 594,02

09/04/2019

5

1232

27 858,98

1

1

23,00

10/04/2019

19

15001

339 322,52

12

1465

33 186,02

11/04/2019

18

5052

113 174,84

54

10752

243 732,98

12/04/2019

13

3673

81 203,84

8

951

21 332,48

15/04/2019

8

1221

27 713,44

51

7496

172 262,22

16/04/2019

24

7136

158 646,72

9

1751

38 991,42

17/04/2019

21

8601

187 594,34

17

3601

79 004,04

18/04/2019

7

1471

32 085,78

71

10671

238 588,92

23/04/2019

15

9000

206 070,00

38

10971

251 799,64

24/04/2019

12

1681

38 771,40

52

8875

206 121,28

25/04/2019

21

5508

125 112,10

10

782

17 961,94

26/04/2019

4

1801

40 782,66

10

1801

41 017,98

29/04/2019

12

2000

45 150,00

25

4011

90 908,82

30/04/2019

31

3222

72 166,96

8

1201

27 122,48

02/05/2019

51

7439

163 594,74

14

1301

28 793,64

03/05/2019

35

7251

155 701,60

70

7389

159 278,54

06/05/2019

35

10001

211 595,38

84

9288

196 859,28

07/05/2019

16

1577

34 124,80

59

6954

153 182,42

08/05/2019

19

2495

53 971,32

15

1831

39 878,80

09/05/2019

25

4751

100 796,60

5

551

11 593,60

10/05/2019

9

6001

125 020,94

23

2001

42 484,94

13/05/2019

50

5846

118 610,14

4

267

5 442,80

14/05/2019

4

521

10 695,76

55

6690

137 784,60

15/05/2019

10

1457

29 878,32

18

2267

46 576,98

16/05/2019

10

1316

27 240,62

45

6666

139 620,50

17/05/2019

5

651

13 686,10

22

1951

41 242,10

20/05/2019

12

3101

64 589,24

6

606

12 641,54

21/05/2019

3

101

2 120,96

17

1696

35 796,94

22/05/2019

11

1146

24 449,50

18

1646

35 300,84

23/05/2019

11

985

20 586,96

7

835

17 550,36

24/05/2019

2

1001

21 741,40

42

5035

108 404,94

27/05/2019

6

417

9 035,20

6

501

11 121,92

28/05/2019

8

842

18 033,76

7

842

18 220,80

29/05/2019

5

601

12 831,50

11

1028

22 078,80

30/05/2019

3

620

13 280,96

8

647

13 903,66

31/05/2019

17

3187

69 068,02

10

1315

28 540,26

03/06/2019

7

1117

23 961,04

12

1503

32 475,08

04/06/2019

6

2001

43 621,58

20

2001

43 571,58

05/06/2019

3

186

4 055,00

3

301

6 622,00

06/06/2019

6

1116

24 441,60

10

1040

23 015,66

07/06/2019

11

3886

83 784,76

1

1

21,86

10/06/2019

13

4001

85 661,56

1

1

21,56

11/06/2019

60

35951

680 608,34

34

5501

113 951,34

12/06/2019

8

3080

57 561,66

66

15080

282 409,44

13/06/2019

40

10076

192 390,34

38

8726

167 352,83

14/06/2019

55

17664

334 160,87

13

4347

82 509,15

17/06/2019

24

6676

122 948,30

30

5176

95 328,38

18/06/2019

12

6446

117 106,80

37

5046

92 139,91

19/06/2019

3

289

5 271,29

39

6189

113 413,20

20/06/2019

86

14092

253 971,11

25

3173

57 913,25

21/06/2019

23

3169

56 804,05

24

5101

91 662,20

24/06/2019

44

6433

114 726,43

53

13777

247 202,33

25/06/2019

70

17001

305 644,04

32

10001

186 518,48

26/06/2019

36

6573

115 400,86

62

8573

151 026,87

27/06/2019

54

7894

139 933,44

39

7894

141 131,01

28/06/2019

8

1001

17 617,63

10

3651

64 979,63